Dr. Chen WANG is the Vice President of the Chinese Academy of Engineering, President of the Chinese Academy of Medical Sciences and Peking Union Medical College, Director of the National Center for Respiratory Medicine, Vice Chair of the Global Alliance Against Chronic Respiratory Diseases，Board Member of the Global Alliance for Chronic Diseases, and commissioner of The Lancet COVID-19 Commission, He is also an academician of the Chinese Academy of Engineering, an international member of the National Academy of Medicine, a foreign member of Academia Europaea, an ordinary member of the European Academy of Sciences and Arts, and a member of the CAMS Academic Advisory Committee. 

Dr. Wang has over 30 years of experience and specialties in pulmonary and critical care medicine. His primary areas of research include clinical and basic research for complex conditions in respiratory medicine, public health, and health policy. His research and policy interests also include medical education, health system reform and medical technology innovation system. Dr. Wang has published more than 250 articles in international medical journals, including New England Journal of Medicine and The Lancet.

Sir Muir Gray

University of Oxford

Speech Topic: The three revolutions to save universal healthcare

Muir Gray has had a career in public health with a number of themes including

·  the management of knowledge, being the first Secretary of the Cochrane Collaboration and setting up the first Centre for Evidence Based Medicine,

·  population ageing and,

·  in the last twenty years, Value Based Healthcare.

He is based in Oxford and heads the Optimal Ageing Programme and the Oxford Value and Stewardship Programme. The mission of the Oxford Value and Stewardship Programme is to bring about a transformation in healthcare shifting the primary focus from

·      Quality of service to outcomes

·      Outcomes for individuals to outcomes for individuals and populations

·      Hospitals and primary care centres to systems and networks

·      Efficiency to Value

·      Good service delivery for patients to providing care for whole populations and reducing inequity

·      A culture of quality improvement to a culture of stewardship  

All of the former issues such as quality and efficiency remain of absolute necessity, but they are not sufficient to meet the challenge of need and demand increasing faster than resources. The reason for this growing gap is not primarily population ageing, because many of the key problems can be prevented or delayed as the Lancet Commission on Dementia has emphasized, but what has been called the relentless increase in the volume and intensity of clinical practice. There is a need for clinicians to be given responsibility not just for providing evidence-based care at high levels of quality and efficiency but also for the stewardship of resources, namely their allocation and use for the benefit of the whole population.

Prof. Gabriel Leung

The University of Hong Kong

Speech Topic: Understanding Hong Kong’s path to becoming the world’s longest living population (To be published)

Gabriel Leung is the fortieth Dean of Medicine (2013-), inaugural Helen and Francis Zimmern Professor in Population Health and holds the Chair of Public Health Medicine at the University of Hong Kong. He was Hong Kong's first Under Secretary for Food and Health (2008-11) and fifth Director of the Chief Executive's Office (2011-2) in government.  A specialist in public health medicine by training, Leung is one of the region’s leading epidemiologists and global health exponents.  His research defined the epidemiology of three novel viral epidemics, namely SARS in 2003, H7N9 influenza in 2013 and most recently COVID-19. In parallel, he leads several large-scale longitudinal cohorts, tracking tens of thousands of lives to study the fundamental causes of non-communicable conditions and to explain the health impacts of contemporary social phenomena.  He led Hong Kong government's response against the 2009 influenza pandemic. He has been an official adviser to the Hong Kong SAR and Chinese Central People’s Governments, as well as to numerous overseas jurisdictions and international agencies including the World Health Organisation.  He serves as a Governor of The Wellcome Trust and is an elected member of the US National Academy of Medicine.

Dr. Bin Cao

China-Japan Friendship Hospital 

Speech Topic: Viral Pneumonia and viral sepsis

Vice President of China-Japan Friendship Hospital

Director of Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital

Vice Director of National Center for Respiratory Medicine

Professor of Capital Medical University

Professor of Tsinghua University-Peking University Joint Center for Life Sciences.

President-elect of Chinese Thoracic Society (CTS)

l Research Interest

1. Epidemiology, clinical characteristics, and treatment of viral pneumonia

2. Molecular and cellular basis of the pathogenesis of viral pneumonia

3. Diagnosis and treatment strategy of infections by drug-resistant pathogens

l Academic Contributions

Dr. Cao has published more than 200 peer reviewed articles and reviews, among which 9 representative articles are published in Lancet or NEJM. Five articles are listed as Highly Cited Paper in ESI and 10 articles are recommended by F1000Prime and 4 articles are cited by WHO or NIH guidelines. Dr. Cao firstly reported clinical characteristics of COVID-19  and risk factors for severe disease. He firstly proposed SARS-CoV-2 viral sepsis which helps clinicians better understand the mechanism of severe COVID-19. He is also leading the antiviral clinical trials in China, including Remdesivir and lopinavir-ritonavir.

Prof. Ajit Lalvani

Imperial College London

Speech Topic: Community transmission of SARS-CoV-2 Delta variant in highly vaccinated populations (To be published)

Chair of Infectious Diseases,

Director, National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections,

Director, Tuberculosis Research Centre,

National Heart and Lung Institute,

Imperial College London and Imperial College Healthcare NHS Trust

Ajit leads a multidisciplinary programme of public health research to protect the health of the population from the most serious respiratory infections: flu, TB and COVID-19. The Health Protection Research Unit that he directs is a national-level partnership between Imperial College London, Public Health England (now UKHSA) and several NHS Hospitals.  Ajit’s patient-based research aims to understand the body’s natural mechanisms of protection against TB, flu and SARS-CoV-2.  He translates his discoveries into innovative practical solutions to improve patient care and public health. These include the blueprint for a universal pandemic influenza vaccine, discovering the mechanism of action of BCG vaccine, the first rapid blood test for TB (IGRA/T-SPOT.TB) and new national screening programmes for latent TB which contributed to the recent halving of England’s TB burden. He has raised >£38 million in research funding and published >170 research papers, cited >11,000 times.  He is committed to reversing health inequalities by tackling the social determinants of health through innovative, community-based approaches, as pioneered by The Bromley by Bow Centre which he chairs. He also chairs the Strategic Advisory Board of the India Alliance, India’s most esteemed medical research funding organization and is a Governor of The Science Museum Group. 

Dr. Kenneth Anthony Fleming

University of Oxford

Speech Topic: The Lancet Commission on Diagnostic：transforming access to diagnostics

The Lancet Commission on Diagnostic：transforming access to diagnostics

Dr Fleming has been an academic pathologist for over 40 years. His research interests include the pathogenesis of Primary Sclerosing Cholangitis, and the molecular analysis of tissue.  He has over 200 publications and a H-index of 49.

Dr Fleming has had several major leadership positions in academic medicine, including appointment as the inaugural Head of the Oxford Medical Sciences Division (Dean of Medicine) from 2000 till 2008. He was also Deputy Head of the UK Council of Medical Schools from 2002-5.

Since 2008, the problems of lack of pathology in many countries have been his focus.  He has set up a MMed for Pathology in Zambia, set up and directed the International Department at the Royal College of Pathologists and been Senior Adviser for Pathology to the Centre for Global Heath at the NCI.  He is currently chairing a Lancet Commission on Diagnosis and is serving as a WHO adviser in several areas of pathology.

Prof. Annie NY Cheung

The University of Hong Kong

The Lancet Commission on diagnostics: transforming access to diagnostics 

Profesor Cheung is Laurence L T Hou Professor in Anatomical Molecular Pathology and Clinical Professor, The University of Hong Kong. 

Professor Cheung is active in international, regional and local organization and professional bodies. She is Commissioner, Lancet Commission on Diagnostics and Director, International Collaboration on Cancer Reporting (ICCR) Board of Directors, as well as Advisor to Executive Board, Asian Oceania Research on Genital Infections and Neoplasia and Subcommittee on Gynaecological Pathology, Chinese Society of Pathology, China Medical Association as well as Member, Cancer Expert Working Group on Cancer Prevention and Screening, Department of Health Hong Kong. She has also been Standing Member, Editorial Board of 5th Edition WHO Classification of Tumours, President of The Hong Kong College of Pathologists and Hong Kong Society of Colposcopy and Cervical Pathology as well as Council Member of the International Federation for Cervical Pathology and Colposcopy and International Society of Gynaecological Pathologists.

Professor Cheung is experienced in pathology laboratory management. Her research focuses on diseases of female genital tract. She has received multiple awards on medical education and research from international and local organizations and institutes.

Prof. Peng Gong

The University of Hong Kong 

Speech Topic: Health and Climate Change, China and the World

Peng Gong is Chair Professor of global sustainability and Vice President for Academic Development, University of Hong Kong. He was professor and Chair of the Department of Earth System Science, Dean of School of Sciences, at Tsinghua University (Beijing, China). He had taught in the Department of Geomatics Engineering at the University of Calgary (Canada) between 1991 and 1994, and had been on faculty in the Department of Environmental Science, Policy and Management at the University of California, Berkeley (CA, USA) between 1994 and 2015. In 2000, he founded the International Institute for Earth System Science at Nanjing University (China) and in 2004, he served as the founding director of the State Key Laboratory of Remote Sensing Science, jointly sponsored by the Institute of Remote Sensing Applications of the Chinese Academy of Sciences and Beijing Normal University. His major research interests include mapping, monitoring and modeling of global environmental change, and modelling of environmentally related infectious diseases such as schistosomiasis, avian influenza, dengue, and COVID-19, and healthy and sustainable cities. 

He is the author/co-author of over 600 articles and 8 books. He chaired/co-chaired 7 Lancet Commission reports on climate change and health and healthy cities in China.  From 2004 to 2006, he was one of the nine members on the Board of Overseas Advisors to the Ministry of Science and Technology of China. He won the distinguished teacher award from Beijing, the 1994 Talbot Abraham Grand Award from the American Society for Photogrammetry and Remote Sensing, the 2008 Recipient of Outstanding Contribution Award in Remote Sensing from the Association of American Geographers, and one of the 10 Outstanding Authors Award in 2016 from the Joint Board of Science China and Scientific Bulletin.

Prof. Marina Romanello

University College London

Speech Topic: The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future

The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future

Marina is Research Director for The Lancet Countdown: tracking progress on health and climate change, where she leads the research of the collaboration, and is in charge of the scientific development and refining of the Lancet Countdown's indicators. She trained as a Biochemist in the University of Buenos Aires, Argentina, and carried out research on environmental nanotoxicology in the Instituto Tecnologico de Buenos Aires and holds a PhD in biomedical sciences from the University of Cambridge. She also worked as a Postdoctoral Research Fellow at the Francis Crick Institute in London, studying the environmental drivers of cancer onset. As part of her role at the Lancet Countdown, she leads on the activities of over 90 collaborators, to produce scientific evidence on the health dimensions of climate change.

Prof. Jing Wu

China CDC 

Speech Topic: Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18

Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18

Jing WU, PhD, MD, MPH, is the Director of the National Center for Chronic and Non-communicable Disease Control and Prevention (NCNCD), the Chinese Center for Disease Control and Prevention (China CDC). She obtained her PhD in epidemiology and biostatistics in the Health Center, Peking University and completed post-doctoral training at Harvard University. Dr. Wu is a member of the WHO special working group on Chronic Disease Control and Prevention, an expert member of the Disease Control and Prevention Expert Committee, a member of the Basic Public Health Services Committee, the National Health Commission, China; an expert member of the Life Science and Human Health Expert Committee, and she sits on the China Association for Science and Technology United Nations Consultative Board. She also takes important roles in some academic institutions, including the Chinese Preventive Medicine Association, and the Chinese Health Information Association. Dr. Wu has hosted and engaged many important research projects. She has published more than 200 papers and monographs.

Prof. An Pan

Tongji Medical College 

Speech Topic: The Lancet Series of Obesity in China: what, why, and how?

Obesity in China

The Lancet Diabetes & Endocrinology

Dr. Pan is a professor at the School of Public Health, Tongji Medical College, Huazhong University of Science and Technology. His research mainly focuses on the determinants and consequences of obesity and chronic metabolic diseases, like type 2 diabetes and cardiovascular disease. He has published over 270 papers with citations over 15500 and an H-index of 66, including papers on NEJM, JAMA, BMJ, and Lancet Diabetes & Endocrinol. Dr. Pan is supported by the NSFC regular and key projects, National key Research & Development project, and are establishing cohort studies for type 2 diabetes and gestational diabetes mellitus to investigate their causes and consequences. Dr. Pan currently serves as an associate editor for the Am J Clin Nutr, and Nutr & Metab, and on the editorial board for several other international and Chinese journals. Dr. Pan is also the vice chair for the Basic Nutrition Council and Nutritional Epidemiology Council of the Chinese Nutrition Society, and member of the Epidemiology Council of the Chinese Preventive Medicine Association.